// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can